Latest: Abzena Launches EpiScreen® 2.0 Immunogenicity Platform | Learn more
- About
- Main Menu
- Main Menu
- Leadership Team
- Our History
- Locations
- Capabilities
- Main Menu
- Main Menu
- Bioconjugates & Chemistry
- Biologics
- Resources
- Careers
- Contact
We tailor our service to your needs to deliver expert assessments of target molecules, immunization strategies and antibody screening cascades.
We apply innovative approaches and equipment to generate robust data that ensures discovery and supports the selection of the best antibody candidates for your development program.
Our Hybridoma MAX™ custom mouse monoclonal antibody discovery service maximizes the number of antibodies discovered through a dual, high-throughput screening platform that creates more candidates for development.
Our methods ensure high affinity antibodies and where required cross-reactivity with the target, and include:
Hybridoma Sequencing
The asset you’re developing right now can make a real difference for human health. Let us use our wealth of experience to deploy the best technologies, shorten lead times and implement effective risk mitigation strategies.